Tumor‐targeted and immune‐targeted monoclonal antibodies: Going from passive to active immunotherapy

E-ISSN： 1545-5017|62|8|1317-1325

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.8, 2015-08, pp. : 1317-1325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal Antibodies

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 9, 1993-09 ,pp. : 533-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantum dots for tumor-targeted drug delivery and cell imaging

By Misra R DK

Nanomedicine, Vol. 3, Iss. 3, 2008-06 ,pp. : 271-274

Future Medicine

Access to resources Recommend Favorite

Tumor‐targeted intracellular delivery of anticancer drugs through the mannose‐6‐phosphate/insulin‐like growth factor II receptor

INTERNATIONAL JOURNAL OF CANCER, Vol. 126, Iss. 8, 2010-04 ,pp. : 1966-1981

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ultrasonic tumor imaging and targeted nanobubbles

Nanomedicine, Vol. 2, Iss. 4, 2007-08 ,pp. : 411-413

Future Medicine

Access to resources Recommend Favorite

Recalcitrant psoriatic uveitis and anti‐tumor necrosis factor‐α monoclonal antibodies: experience from a psoriasis referral center

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 9, 2015-09 ,pp. : 1105-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite